India-US trade pact talks may progress post-Section 301 investigations, impacting tariffs and negotiations on excess capacity findings.

India secures a 10% US tariff under Section 301, but trade uncertainties, particularly in pharma and oil, persist.

The US has placed India in a lower tariff bracket of ten percent. Approximately forty-five percent of India's exports to the US remain outside this additional duty. The remaining…

India-US trade pact talks may progress post-Section 301 investigations, impacting tariffs and negotiations on excess capacity findings.